CoChat

The ileal bile acid transporter inhibitor A4250 decreases serum bile acids by interrupting the enterohepatic circulation

Open access
Graffner, H., Gillberg, P.‐G., Rikner, L., Marschall, H.‐U. · 2016 · Alimentary Pharmacology & Therapeutics
Cited by 94

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Summary: Background: Reabsorption of bile acids from the intestine by ileal bile acid transporter is pivotal for the enterohepatic circulation of BA s and sterol homoeostasis. Aim: To assess tolerability and study, bile acid metabolism in a phase 1 trial with the selective ileal bile acid transporter inhibitor A4250. Methods: A randomised double‐blind, single‐ascending dose (SAD) and multiple‐ascending‐dose study consisting of five cohorts comprising 40 individuals with a single administration of A4250 (0.1, 0.3, 1, 3, or 10 mg) or placebo and three cohorts comprising 24 individuals with a 1‐week administration of A4250 (1 or 3 mg once daily or 1.5 mg twice daily) or placebo. For the multiple‐ascending‐dose study, bile acids were measured by HPLC‐MS in plasma and faeces, and fibroblast growth factor 19 (FGF 19) and 7α‐hydroxy‐4‐cholesten‐3‐one (C4) were measured in plasma. Results: No serious adverse events occurred and all participants finished the trial per protocol. At the end of the multiple‐ascending‐dose study, plasma total bile acids and FGF 19 decreased by 47% and 76%, respectively, at 3 mg/day (P < 0.01), and by 15% and 16%, respectively, at 1.5 mg twice daily (P < 0.05). Plasma C4 and faecal bile acids increased at all dose regimens, by 555%, 664%, 292% and 338%, 421%, 420%, respectively (P < 0.01–0.05). The primary bile acids cholic and chenodeoxycholic acids constituted the majority of faecal bile acids in the A4250‐treated groups. Conclusions: A4250 is well tolerated. By blocking ileal bile acid transporter in the terminal ileum, it highly efficiently interrupts the enterohepatic circulation of BA s, and should be of benefit to patients with cholestatic liver diseases. Clinical Trial registration EudraCT 2013‐001175‐21

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/apt.13457

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

Metadata

Authors
Graffner, H., Gillberg, P. ‐., Rikner, L., & Marschall, H. ‐.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2015-11-02
Volume
43
Issue
2
Pages
303-310
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2106191318
Cited by
94
References
4
FWCI
3.64
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.